Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hangzhou Synrx Therapeutics Biomedical Technology Co., Ltd

Clinical trials sponsored by Hangzhou Synrx Therapeutics Biomedical Technology Co., Ltd, explained in plain language.

Trials to join now! 1

New cancer drug combo enters human testing

Disease control Recruiting now

This early-stage study is testing the safety and initial effects of a new drug called SYN818 when given with an existing cancer drug, olaparib. It is for adults with advanced or metastatic solid tumors (like ovarian or breast cancer) that have specific genetic changes (BRCA mutat…

Phase: PHASE1 • Sponsor: Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC